Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosign Technologies Inc BITKF

Biosign Technologies Inc is a Canada based company engaged in the development and selling of cloud-based medical and healthcare software products. Its solutions have applications in clinic management, home care operations, health monitoring and virtual care management. The group derives its revenue from monthly recurring fees, one-time setup charges, training, professional services and the sale of hardware. The software is delivered through the cloud from the company's hosting facilities.


GREY:BITKF - Post by User

Bullboard Posts
Comment by DAbramovon Dec 08, 2005 10:14am
129 Views
Post# 9987632

RE: Bio halted not delisted...

RE: Bio halted not delisted...This is the funniest post I have read in a LOOONG time! Thank you for the cheers in this holiday season Question for you: How is having a stock halted twice over its intended list of directors and then have the proposed new individuals rejected by the TSX serve well for the company? (I know it's a loaded sentence, but I'm just baffled by the statements you've made). All of this works on BIO's credibility, not to mention the frequent purchases & sales of bio shares by RR and his spouce. I urge you to look through insider reports and see how those transactions have taken place. i.e. how many warrants were exercised, how many shares were purchased on the public market and then DUMPED on to the same public market at significantly greater prices. Moreover, how will November sales of Sucanon improve a stock's share price when it's HALTED? We may indeed have to wait until the new year (January or later) to see trading resume in the stock once again. US trading continues because TSX regulations do not apply to the US. You'll see the share price of BIOHF continue falling as long as BIO maintains a halt on the TSX. Anyone care to disagree? Your comments are always welcome. Cheers!
Bullboard Posts